2-dose vaccine 'appears to be enough,' FDA adviser says
Dr. Paul Offit, a member of the U.S. Food and Drug Administration's vaccine advisory committee, said a two-dose COVID-19 vaccine "appears to be enough" to curb infection, rather than adding a booster shot.
"You look at states in the United States that have high immunization rates with a two-dose vaccine, it appears the two doses appears to be enough to be able to control this infection," Offit, who is also the director of the Vaccine Education Center at Children's Hospital of Philadelphia, told ABC News on Thursday night. "I think the critical issue here is not going to be boosting the vaccinated. I think if we really want to get on top of this pandemic, it's going to be about vaccinating the unvaccinated."
The FDA's vaccine advisory committee is set to hold a key meeting on COVID-19 vaccine booster shots on Sept. 17, just three days before the Biden administration plans to begin offering the shots to Americans.
"If the companies or the FDA can make a case that there has been an erosion in protection against severe critical disease and that that erosion in protection against severe disease would be mediated or eliminated by a third dose, then we could move forward," Offit said. "But to date, we really need to see those data to be able to make that decision."